Spots Global Cancer Trial Database for malt lymphoma
Every month we try and update this database with for malt lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trial of Bendamustine And Rituximab for Patients With Previously Untreated Extranodal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma | NCT01015248 | MALT LYMPHOMA | Rituximab and B... | 18 Years - 84 Years | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | |
| Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma | NCT00117156 | Lymphoma, Non-H... MALT Lymphoma | Fludarabine Rituximab | 18 Years - | Dana-Farber Cancer Institute | |
| Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma | NCT00201422 | MALT Lymphoma | Omeprazole, Amo... | - | National Health Research Institutes, Taiwan | |
| Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Type | NCT00923663 | MALT Lymphoma | Lenalidomide | 18 Years - 80 Years | Medical University of Vienna | |
| Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue | NCT01611259 | Lymphoma of the... | Rituximab and L... | 18 Years - | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma | NCT03261349 | Indolent Lympho... | Ledipasvir and ... | 20 Years - | National Taiwan University Hospital | |
| Velcade in MALT Lymphoma Patients | NCT00373906 | MALT Lymphoma | Bortezomib (Vel... | 18 Years - | Medical University of Vienna | |
| Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma | NCT00201422 | MALT Lymphoma | Omeprazole, Amo... | - | National Health Research Institutes, Taiwan | |
| Trial of Lenalidomide in Patients With Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT) Type | NCT00923663 | MALT Lymphoma | Lenalidomide | 18 Years - 80 Years | Medical University of Vienna | |
| Velcade in MALT Lymphoma Patients | NCT00373906 | MALT Lymphoma | Bortezomib (Vel... | 18 Years - | Medical University of Vienna | |
| Trial of Bendamustine And Rituximab for Patients With Previously Untreated Extranodal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma | NCT01015248 | MALT LYMPHOMA | Rituximab and B... | 18 Years - 84 Years | Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | |
| Rituximab Plus Lenalidomide in Patients With Mucosa Associated Lymphoid Tissue | NCT01611259 | Lymphoma of the... | Rituximab and L... | 18 Years - | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma | NCT03261349 | Indolent Lympho... | Ledipasvir and ... | 20 Years - | National Taiwan University Hospital | |
| A Safety and Effectiveness Study of Vaccine Therapy in Patients With Indolent Lymphoma | NCT00081809 | Lymphoma, Folli... Lymphoma, Small... | autologous huma... | - | Agenus Inc. | |
| Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma | NCT01808599 | MALT Lymphoma | Chlorambucil Rituximab i.v. Rituximab s.c. | 18 Years - | International Extranodal Lymphoma Study Group (IELSG) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
